Mike Grady

Background

About Mike Grady

Diabetes & healthcare technology executive with a proven track record of delivering global clinical & commercial evidence to maximize brand recognition and product adoption. Selected achievements:• Designed over 80% of LifeScan’s clinical studies in the last 15 years (example; https://pmc.ncbi.nlm.nih.gov/articles/PMC6238868/).• Content creation for over 75% of commercial clin/med claims in the last 15 years for detail aids, brochures and campaigns for meters, apps and lancing products. • ~50 journal publications (primarily as 1st author) leading to at least views by healthcare professionals, supporting OneTouch awareness and product adoption.• Designed innovative digital therapeutics study in partnership with Noom, Welldoc, Fitbit and Cecelia Health. Published with Steve Co-designed & published CGM survey with the Type 1 Diabetes Exchange (https://diabetesjournals.org/clinical/article/42/1/104/153502/Perceptions-of-Continuous-Glucose-Monitoring).• CGM study collaborations with Andreas Pfutzner on CGM interferents and performance with Guido Freckmann (https://journals.sagepub.com/doi/10.1177/1932296818812062).• Initiated Real-World Evidence (RWE) strategy to create multiple articles showcasing value of OneTouch by harnessing app uploads from our connected glucose meters (https://link.springer.com/article/10.1007/s13300-023-01415-3).• Creator of HERO online study method (with IPSOS) to gain fast, low-cost HCP claims (https://journals.sagepub.com/doi/10.1177/1932296820946112).• Co-creator of AI-driven clinical knowledge hub using over key clinical articles that I had selected over the years, enabling rapid insights generation. • Co-authored with leading healthcare and diabetes KOLs (e.g. Richard Bergenstal, Steve Edelman, Gregg Simonson, Andreas Pfutzner, Oliver Schnell, Brij Makkar & Guido Freckmann).